Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1999
10/27/1999EP0951565A1 Improved probing of specific nucleic acids
10/27/1999EP0951564A1 Method for the detection of compounds that modulate the effects of the obese (ob) protein
10/27/1999EP0951563A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
10/27/1999EP0951560A1 Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them
10/27/1999EP0951559A1 Recombinant pox virus for immunization against tumor-associated antigens
10/27/1999EP0951558A1 Methods for producing parthenocarpic or female sterile transgenic plants
10/27/1999EP0951557A1 Methods for generating and screening novel metabolic pathways
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951555A2 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
10/27/1999EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999EP0951553A2 Adenovirus e4 proteins for inducing cell death
10/27/1999EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
10/27/1999EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999EP0951550A1 Mammalian cytokine related to il10
10/27/1999EP0951549A1 Mammalian chemokines
10/27/1999EP0951548A1 Mammalian icyp (iodocyanopindolol)receptor and its applications
10/27/1999EP0951547A1 NOVEL SEQUENCES OF p56 PROTEINS WHICH AFFECT K-ATP CHANNELS
10/27/1999EP0951546A2 Compositions and methods of use for osteoclast inhibitory factors
10/27/1999EP0951545A2 Human gtp-binding proteins
10/27/1999EP0951544A2 Methods for administration of recombinant gene delivery vehicles for treatment of human disease
10/27/1999EP0951543A1 Human glycine transporter
10/27/1999EP0951542A2 Secreted proteins and polynucleotides encoding them
10/27/1999EP0951541A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
10/27/1999EP0951540A2 Antisense nucleic acids and hammerhead ribozymes
10/27/1999EP0951539A1 Vectorial cloning system of dna
10/27/1999EP0951538A2 PARTIAL SEQUENCES OF PURINE BIOSYNTHESIS GENES FROM $i(ASHBYA GOSSYPII) AND THEIR USE IN THE MICROBIAL RIBOFLAVIN SYNTHESIS
10/27/1999EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999EP0951536A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/27/1999EP0951534A1 Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin
10/27/1999EP0951533A1 Vectors and methods for the mutagenesis of mammalian genes
10/27/1999EP0951476A2 Complement inhibitor
10/27/1999EP0951469A1 Novel compounds
10/27/1999EP0951296A1 NOVEL FtsL
10/27/1999EP0853630A4 Detecting genetic predisposition to periodontal disease
10/27/1999EP0769144B1 Assay for inhibitors of dp-1 and other dp proteins
10/27/1999EP0759938A4 Neurogenic differentiation (neurod) genes and proteins
10/27/1999EP0695353A4 Selecting genes encoding catalytic antibodies
10/27/1999EP0682716A4 Rna assays using rna binary probes and ribozyme ligase.
10/27/1999EP0590082B1 Antisense oligonucleotide inhibition of the ras gene
10/27/1999EP0533862B1 Recombinant human factor viii derivatives
10/27/1999CN1233326A Process for determining the status of an organism by peptide measurement
10/27/1999CN1233291A Method for recombinant adeno-associated virus-directed gene therapy
10/27/1999CN1233290A Antifungal proteins, DNA coding therefore, and hosts incorporating same
10/27/1999CN1233289A TNF-Beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
10/27/1999CN1233288A GnRH-leukotoxin chimeras
10/27/1999CN1233287A Artificial promoter libraries for selected organisms and promoters derived from such libraries
10/27/1999CN1233286A Alpha-amylase fused to cellulose binding domain, for starch degradation
10/27/1999CN1233255A Preparation of purified (poly) peptides
10/27/1999CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999CN1233185A Nucleosome-based anti-tumor compositions
10/27/1999CN1232872A Overproduction of riboflavin in yeast
10/27/1999CN1232608A Asymmetrical cytomixis method for leaf-unrolling Chinese cabbage and the regenerated plant obtained thereby
10/27/1999CN1045995C Method of inducing lysine overproduction in plants
10/27/1999CN1045994C Modification of plant viruses or their effects
10/26/1999US5973233 Cytoplasmic male sterility system production canola hybrids
10/26/1999US5973231 For transforming hosts with pesticidal protein; killing pests with host transformed to express protein
10/26/1999US5973230 Pinosylvine synthase genes
10/26/1999US5973229 Isolated, purified protein encoding cdna; to alter plant's sensitivity to certain herbicides
10/26/1999US5973228 Coniferin beta-glucosidase cDNA for modifying lignin content in plants
10/26/1999US5973227 Flax transformation
10/26/1999US5973226 Method of changing the composition of the phospholipid produced by the living body and recombinant vector therefor
10/26/1999US5973225 Cloned and sequenced gene correlated with qualitative characteristics of duram wheat meal and bran; recombinant expression vector in host cells; microorganism transformed with vector
10/26/1999US5973138 Method for purification and manipulation of nucleic acids using paramagnetic particles
10/26/1999US5973137 Low pH RNA isolation reagents, method, and kit
10/26/1999US5973136 Inverted chimeric oligonucleotides
10/26/1999US5973135 DNA comprising plum pox virus and tomato spotted wilt virus cDNAS for disease resistance
10/26/1999US5973134 Rat CNP complementary DNA and precursor protein
10/26/1999US5973133 Mutant S182 genes
10/26/1999US5973132 Expression of dna coding for house dust mite allergens.
10/26/1999US5973123 Monoclonal antibody, or fragment thereof, which has an affinity for native melanoma inhibitory activity protein
10/26/1999US5973120 Bovine and human polynucleotides and peptides expressed by such polynucleotides which are useful in detecting goodpasture antibodies and treating goodpasture syndrome.
10/26/1999US5973119 Cyclin E genes and proteins
10/26/1999US5973118 A polypeptide which codes a trypsin inhibitor; for purification of tissue plasminogen activators
10/26/1999US5973117 Isolated and purified receptor protein endogenous to rt, bovine, or human, capable of binding a pituitary adneylate cyclase activating polypeptide (pacap) or salt, and amino acid sequences encoding it; diagnostic, e.g. of neuropathy
10/26/1999US5973116 Compounds for targeting
10/26/1999US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999US5972901 Making a composition for delivering an oligonucleotide to a mammalian cell by providing a peptide target binding moiety being capable of binding to a serpin enzyme complex receptor, polylysine, an oligonucleotide vector; conjugating, coupling
10/26/1999US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering
10/26/1999US5972899 Apoptosis induced by Shigella IpaB
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972886 Amino acid sequences, a gene coding for stimulating cell differentiation of megakaryocytes; increasing blood platelet cells
10/26/1999US5972716 With sample tube having surface roughness which reduces background due to contamination of tube holder in apparatus; for polymerase chain reactions
10/26/1999US5972708 Plasmid stabilization
10/26/1999US5972707 Gene delivery system
10/26/1999US5972706 Recombinant cytopathic viruses which are capable of replication and/or expression of late region genes in neoplastic mammalian cells but are essentially non-replicable in non-neoplastic cells, methods for constructing and
10/26/1999US5972705 Sequence-specific methylation of ribonucleic acid
10/26/1999US5972704 HIV nef targeted ribozymes
10/26/1999US5972702 There also exists a need to identify the gene(s) responsible for osteopetrosis and to provide a genetic therapy for treating osteopetrosis. an object of the invention is to provide compounds that desirably influence the bone remodeling
10/26/1999US5972701 Nucleotide sequence of ribo- or deoxyribonucleotides which may have modified sugars, bases, or phosphates; for hybridization and cleavage of rna targets; treatment of disease
10/26/1999US5972700 Tm4 mycobacteriophage that introduces dna of interest into mycobacteria.
10/26/1999US5972699 Method and reagent for inhibiting herpes simplex virus replication
10/26/1999US5972698 Tryptase is expressed virtually exclusively by mast cells.
10/26/1999US5972693 Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
10/26/1999US5972692 For sensitive, safe, convenient, rapid detection by hybridization; electrode with single stranded nucleic acid probe immobilized on surface, reaction vessel for denatured sample, washing means, vessel for storage of detection means
10/26/1999US5972690 DNA strands useful for the synthesis of xanthophylls and the process for producing the xanthophylls
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999US5972687 Toxin gene from Xenorhabdus nematophilus
10/26/1999US5972683 Mutant type subtilisin YaB and its application
10/26/1999US5972682 Enzymatically active modified subtilisins
10/26/1999US5972680 An aminopeptidase which is involved in insulin regulation.